Výsledky vyhledávání

Akademický článek

Chronic cough associated with COPD exacerbation, pneumonia and death in the general population

Autor: Eskild M. Landt, Yunus Çolak, Børge G. Nordestgaard, Peter Lange, Morten Dahl

Publikováno v: ERJ Open Research, Vol 10, Iss 1 (2024)

Background Chronic cough affects up to 10% of the general population and was previously perceived as a comorbidity of underlying conditions, but is nowadays classified as a disease in its own entity that could confer increased risk of morbidity and m

Externí odkaz: https://doaj.org/article/08516ae04f6e4c0f821e4447369e44f7

Zobrazit plný text záznamu

Akademický článek

α1-Antitrypsin deficiency associated with increased risk of heart failure

Autor: Sine V. Winther, Eskild M. Landt, Børge G. Nordestgaard, Niels Seersholm, Morten Dahl

Publikováno v: ERJ Open Research, Vol 9, Iss 5 (2023)

Background Individuals with α1-antitrypsin deficiency have increased elastase activity resulting in continuous degradation of elastin and early onset of COPD. Increased elastase activity may also affect elastic properties of the heart, which may imp

Externí odkaz: https://doaj.org/article/d112afdd8dd14256b09465b799665140

Zobrazit plný text záznamu

Akademický článek

Low-density lipoprotein cholesterol and risk of COPD: Copenhagen General Population Study

Autor: Josefine Freyberg, Eskild M. Landt, Shoaib Afzal, Børge G. Nordestgaard, Morten Dahl

Publikováno v: ERJ Open Research, Vol 9, Iss 2 (2023)

Background Randomised controlled trials found that low-density lipoprotein (LDL) cholesterol-lowering statins increase lung function and possibly decrease rate of exacerbations in individuals with COPD. However, it is unknown whether high levels of L

Externí odkaz: https://doaj.org/article/0ce32e18c14a4b45a918b09a8d42e24c

Zobrazit plný text záznamu

Low-density lipoprotein cholesterol and risk of COPD: Copenhagen General Population Study

Autor: Josefine Freyberg, Eskild M. Landt, Shoaib Afzal, Børge G. Nordestgaard, Morten Dahl

Publikováno v: Freyberg, J, Landt, E M, Afzal, S, Nordestgaard, B G & Dahl, M 2023, ' Low-density lipoprotein cholesterol and risk of COPD : Copenhagen General Population Study ', ERJ Open Research, vol. 9, no. 2, 00496-2022 . https://doi.org/10.1183/23120541.00496-2022

BackgroundRandomised controlled trials found that low-density lipoprotein (LDL) cholesterol-lowering statins increase lung function and possibly decrease rate of exacerbations in individuals with COPD. However, it is unknown whether high levels of LD

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54afccd15a3d37f0232daba94c6ad592
https://doi.org/10.1183/23120541.00496-2022

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání